newsfilter
← Latest News
PR Newswire·

BioSpecifics Announces Completion of Acquisition by Endo Pharmaceuticals

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with ...